Enhanced Cartilage Defect Repair System
Legal Citation
Summary of the Inventive Concept
A novel system for repairing cartilage defects, comprising a biocompatible scaffold, a composition of cultured allogeneic cells and a resorbable collagen membrane, and optional bioactive molecules and growth factors to enhance integration and tissue remodeling.
Background and Problem Solved
The original patent addresses the limitation of spontaneous repair of chondral lesions, but it has inherent limitations in terms of integration with surrounding tissue and long-term efficacy. The new inventive concept addresses these limitations by incorporating a biocompatible scaffold, bioactive molecules, and growth factors to enhance the repair process.
Detailed Description of the Inventive Concept
The system consists of a biocompatible scaffold with a microstructure designed to promote cell growth and differentiation. The scaffold is configured to enhance the integration of the composition with the surrounding tissue. The composition comprises cultured allogeneic cells and a resorbable collagen membrane. Optional bioactive molecules and growth factors can be applied to the defect site to promote cell recruitment and differentiation, and to enhance the repair process. The system can be personalized using computer-aided design to generate a customized scaffold based on patient-specific defect geometry.
Novelty and Inventive Step
The new claims introduce a biocompatible scaffold and optional bioactive molecules and growth factors, which are not present in the original patent. These components enhance the integration of the composition with the surrounding tissue and promote tissue remodeling, resulting in a more effective and long-lasting repair.
Alternative Embodiments and Variations
Alternative embodiments of the system could include different types of biocompatible scaffolds, such as nanofibrous or hydrogel-based scaffolds. The composition could also be modified to include different types of cells or biomolecules. Additionally, the system could be adapted for use in repairing defects in other tissues, such as bone or skin.
Potential Commercial Applications and Market
The enhanced cartilage defect repair system has significant commercial potential in the orthopedic and sports medicine industries, where there is a high demand for effective and long-lasting treatments for cartilage defects. The system could also be marketed for use in veterinary medicine to treat cartilage defects in animals.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Regenerative medicine, specifically cartilage tissue engineering and repair techniques, involving cell culture, biomaterial scaffolds, and tissue regeneration strategies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or tissue regeneration specialist with expertise in cell culture techniques, biomaterial design, orthopedic tissue repair, and knowledge of cell-scaffold interactions
Obviousness Rationale
A PHOSITA would recognize that adding a biocompatible scaffold and growth factors to the existing cartilage repair composition represents a predictable engineering solution to enhance tissue integration and repair outcomes. The proposed modifications represent standard optimization techniques in tissue engineering that would be obvious to implement given the known challenges in cartilage defect repair. The systematic approach of improving cell delivery, scaffold design, and biological signaling follows established principles of regenerative medicine.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,576 |
|---|---|
| Title | Compositions and methods for repairing cartilage defects |
| Assignee(s) | Vericel Corporation |